ABSTRACT
INTRODUCTION
Differential display is a sensitive technique for detecting variations in gene expression between two cellular populations (2) (3) (4) . However, if the populations being studied are genetically distant, then noise will be introduced into the data. This noise contributes to the high false positive rate in the conventional technique. In addition, standard differential display is also labor, time and resource intensive. We have made three modifications to the conventional technique. First, the reverse transcription (RT) of total RNA is primed with random hexamers. Second, PCR amplification products are separated on agarose and visualized with ethidium bromide. Because visualization is direct, excision of the target bands from the gel is more precise. Finally, the secondary amplification step in the conventional technique is eliminated. These modifications reduce the time required to screen a set of primers, reduce false positives from co-migrating bands and reduce the need for radioactive isotopes. Here, we report a demonstration of this modified technique using an animal model of prostate cancer metastasis-the Dunning model (1) . Specifically, the non-metastatic AT.1 and the metastatic MAT-LyLu (MLL) tumors were compared.
MATERIALS AND METHODS
All reagents and cell culture products were obtained from Life Technologies (Gaithersburg, MD, USA) unless otherwise specified.
Cell Culture and Tumor Growth
MLL and AT.1 cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum, 1 U/mL penicillin, 1 µ g/mL streptomycin and 0.25 µ g/mL amphotericin B. The cultures were maintained at 37°C in a humidified atmosphere containing 5% CO 2 .
Tumors were initiated by injecting 1 ×10 6 cells into both flanks of male Copenhagen rats. The tumors were grown until they reached a diameter of 1-2 cm by external palpation (2-3 weeks). The rats were then sacrificed using carbon dioxide, the tumors resected and flash-frozen in liquid nitrogen. The frozen tumors were stored at -80°C until used.
Total RNA Isolation
Approximately 500 mg of tissue were cut from tumors using sterile scalpel blades. The outer layer of tumor was scraped off to reduce contamination from non-tumor tissue and discarded. The tissue was placed into 7.5 mL of TRI ZOL ™, homogenized, and total RNA was isolated following the manufacturer's protocol. The total RNA was then digested with RNase-free, DNase I to eliminate possible contamination from genomic DNA. The digested RNA was extracted with phenol/chloroform, precipitated with ethanol, dissolved in nuclease-free water and stored at -80°C.
Differential Display
Total RNA was reverse transcribed using random hexamers to prime the reaction. Briefly, 2 µ g of total RNA in a total volume of 22 µ L was denatured at 65°C for 5 min and placed on ice. A master reaction mixture was prepared containing 10 mM dithiothreitol, 500 µ M of each dNTP, 100 ng random hexamers (Roche Molecular Biochemicals, Indianapolis, IN, USA), 5 ×first-strand buffer (250 mM Tris-HCl, pH 8.3, 375 mM KCl, 15 mM MgCl 2 ) and 400 U M-MLV reverse transcriptase. Eighteen microliters of the master mixture were added to the total RNA solution and incubated using the following program: 22°C for 10 min; 37°C for 50 min; and 70°C for 15 min. The resultant cDNA was then amplified using 40 random 10-mers (Operon Technologies, Alameda, CA, USA). Each 30 µ L reaction contained 2 µ L of cDNA, 500 nM of one primer, 100 µ M of each dNTP, 1.5 mM MgCl 2 , 10 ×PCR buffer (200 mM Tris-HCl, pH 8.4, 500 mM KCl) and 1 U TaqDNA polymerase. The reactions were incubated at 94°C for 2 min, then amplified for 40 cycles using the following program: 94°C for 2 min; 38°C for 2 min; and 72°C for 1.25 min. This was followed by an elongation step of 15 min at 72°C. Reactions were stored at -20°C until analyzed.
The amplified cDNA was separated on a 14 × 11 cm gel of 2% DNA Typing Grade Agarose in 1 ×TAE buffer (40 mM Tris, 20 mM sodium acetate, 1 mM EDTA, pH 8.0) and visualized with ethidium bromide. A 100 bp ladder was included as a size reference. The DNA Typing Grade agarose was able to resolve bands separated by 50 bp. For each primer tested, three AT.1 tumors were compared to three MLL tumors to reduce the probability of differences occurring by chance. The entire experiment, from the RT step through the separation, was repeated three times, and only consistent differences were chosen for further study. The criteria used to identify differences in mRNA expression between the AT.1 and MLL tumors were: ( i ) similar band intensities within a tumor type, ( ii ) similar between run band intensities and ( iii ) a difference in absorbance of at least two between the AT.1 and MLL bands. Overex -pressed bands that met these criteria were excised from the gel(s), and the cDNA was extracted using the QIAquick ™ Gel Extraction Kit (Qiagen, Valencia, CA, USA). The cDNA was then ligated into the pGEM ® -T Easy vector (Promega, Madison, WI, USA) and used to transform bacteria. The insert was sequenced by the University of Michigan DNA Sequencing Core and used as a reagent in additional studies.
Relative Quantitative PCR and Northern Analysis
Relative quantitative PCR (RQ-PCR) uses expression of a ubiquitous gene to normalize the amount of cDNA used in subsequent PCR experiments to assess the relative expression of a target transcript. Briefly, 50 ng of cDNA were amplified with β -actin primers (Clontech Laboratories, Palo Alto, CA, USA) following the manufacturer's protocol.
Sets of reactions were run over a range of cycles (e.g., 22, 24, 26 and 28). The products were separated on 2% agarose, and the band intensities were compared. The band intensities were compared in a set of reactions with the same cycle count and where no band was saturated. The amount of cDNA used in subsequent reactions was adjusted according to these intensities. For example, if the intensity of band A at 24 cycles was twice the intensity of band B, then 100 ng of B cDNA and 50 ng of A cDNA were used in future reactions. The same procedure was then used to verify differential expression of the target gene using sequence specific primers. Differential expression of the target gene was confirmed if the band intensities were similar within one tumor type for all cycles and of greater absorbance in the tumor from which the original cDNA was derived.
Differential gene expression was also verified by poly(A) + Northern analysis. Briefly, poly(A) + RNA was isolated from 500 µ g of total RNA using the PolyATtract ® System IV (Promega), following the manufacturer's protocol. Then, 2-3 µ g of poly(A) + RNA were separated on a 1.5% agarose gel containing 18% formaldehyde. RNA markers were used as size standards. After separation, the RNA was transferred to a Nytran ® membrane using the TurboBlotter ™System (Schleicher & Schuell, Keene, NH, USA) and following the manufacturer's protocol. The membrane was cross-linked and dried at 80°C for 0.5-2 h in a vacuum oven. The membrane was prehybridized and hybridized in ExpressHyb ™(Clontech Laboratories), following the manufacturer's protocol. The probe was random-prime labeled with α -32 P-dCTP and purified on a SuperSelect ® G-50 column (5 Prime → 3 Prime, Boulder, CO, USA). The membrane was then
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washed and sealed in plastic. The hybridization was visualized by autoradiography. β -actin was used as a control. Figure 1 is a representative gel from a differential display experiment. The band indicated by the arrow meets the criteria for differential expression outlined above. Although not shown, this band pattern was consistent when repeated. Using 40 random 10-mers as amplification primers, we identified 13 differentially expressed cDNAs. One of these, M-C1-700, was cloned and sequenced. A search of the GenBank ® database revealed its sequence to be unique. Figure 2 shows the β -actin PCR products, grouped by tumor, separated on 2% agarose. The bands representing 30 cycles were compared, and the amount of cDNA used in the sequence specific amplification was adjusted according to their relative intensities. Primers specific to the M-C1-700 sequence were used to amplify cDNA from six tumors for 24, 26, 28 and 30 cycles. Figure 3 shows the products of these amplifications, grouped by cycle set, separated on 2% agarose. It can be seen that the band corresponding to the M-C1-700 gene is consistently overexpressed in the MLL tumors and that expression is similar within a tumor type. Figure 4 shows the Northern analysis confirming the overexpression of the M-C1-700 gene in the MLL tumor. Size markers (not shown) were used to estimate the size of the primary transcript at approximately 7 kb. β -actin expression is equal in both tumors.
RESULTS

DISCUSSION
A modified differential display technique was described. This new technique has several advantages over the conventional technique. First, by using random hexamers to prime the RT, the resultant cDNA is more likely to include coding regions because it is not locked to the poly(A) tail of the messenger RNA. Second, separation on agarose and fluorescence detection reduces the need for radioactive isotopes. Also, reactions can be stored and analyzed for convenience because the method of detection will not decay. Finally, the modified method offers a time advantage. Starting with total RNA, 40 primers can be screened in less than one week. Additionally, since there is no secondary amplification step following band identification and isolation, any contaminating (i.e., co-migrating) bands will not be a significant source of false positives. The design of the modified technique results in a higher probability of the target cDNA being selected. The target cDNA will be present at much higher levels than any contaminating cDNA. Thus, during 
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